Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for Surgery

Life 2026 Open access

Read full text
Authors: Or Schubert, Maria Chiara Sighinolfi, F. Gavi, Enrico Panio, Simone Assumma, Antonio Silvestri, Giuseppe Pallotta, V. Cavarra, Pierluigi Russo, Nazario Foschi, Eros Scarciglia, Alessandro Posa
+8 more Alessandro Maresca, Gaetano Gulino, Alessandro Cina, Chiara Ciccarese, R. Iacovelli, Luca Tagliaferri, Roberto Iezzi, Bernardo Rocco
DOI: 10.3390/life16010073
Cited by: 3
References: 37

Abstract

Minimally invasive ablative therapies have emerged as effective and safe alternate approach for the management of renal cell carcinoma (RCC), particularly in patients who are ineligible for surgery due to comorbidities or high operative risk. Techniques such as radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation (CA), and high-intensity focused ultrasound (HIFU) offer kidney-sparing treatment with reduced morbidity. Current evidence suggests that for cT1a tumors (

Fields of Study & Subjects

Renal cell carcinoma treatment Hepatocellular Carcinoma Treatment and Prognosis Ultrasound and Hyperthermia Applications

Publication details

Journal / source
Life
Publisher
MDPI AG
Volume
16
Issue
1
Pages
73–73
Publication date
4 January 2026
Language
EN